Skip to main content

ArriVent BioPharma, Inc.

AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001868279

No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 152 institutions reported holding it in 13F filings for Q3 2026, worth $1.53B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Holders of 5% or more of AVBP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of ArriVent BioPharma, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of AVBP
HolderLatest formStakeChangeFirst filedLatest filingFiling
Infinitum Asset Management, LLC13G/A9.90%4.12M shares0.00 ppfrom 9.90%May 15, 20253 filingsFeb 17, 2026SEC
Suvretta Capital Management, LLC13G/A9.90%3.41M shares–Dec 4, 20242 filingsAug 13, 2025SEC
Hillhouse Investment Management, Ltd.13G/A9.50%3.93M shares–Feb 17, 20261 filingFeb 17, 2026SEC
BlackRock, Inc.13G/A6.80%3.18M shares+1.20 ppfrom 5.60%Oct 24, 20245 filingsJul 27, 2026SEC
OrbiMed Advisors LLC13D/A5.80%2.88M shares−1.70 ppfrom 7.50%Feb 5, 20243 filingsOct 8, 2026SEC
FMR LLC13G/A5.80%2.86M shares−1.00 ppfrom 6.80%Nov 12, 20244 filingsNov 5, 2026SEC
HBM Healthcare Investments (Cayman) Ltd.13G5.40%2.20M sharesNewOct 15, 20251 filingOct 15, 2025SEC
Vivo Opportunity Fund Holdings, L.P.13G5.00%2.47M sharesNewOct 13, 20261 filingOct 13, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

30 Schedule 13D and 13G filings on ArriVent BioPharma, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on AVBP
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 5, 20261:10 PM ETFMR LLCand 1 other13G/A5.80%2.86M shares−1.00 ppfrom 6.80%Sep 30, 2026SEC
Oct 13, 20264:01 PM ETVivo Opportunity Fund Holdings, L.P.and 5 others13G5.00%2.47M sharesNewOct 6, 2026SEC
Oct 8, 20266:39 PM ETOrbiMed Advisors LLCand 3 others13D/A5.80%2.88M shares−1.70 ppfrom 7.50%Oct 6, 2026SEC
Jul 27, 20264:25 PM ETBlackRock, Inc.13G/A6.80%3.18M shares+1.20 ppfrom 5.60%Jun 30, 2026SEC
May 6, 202611:00 AM ETFMR LLCand 1 other13G/A6.80%3.02M shares−1.60 ppfrom 8.40%Mar 31, 2026SEC
Mar 5, 20266:08 AM ETSofinnova Venture Partners IX, L.P.and 4 others13G/A4.10%1.70M shares–Below 5%Dec 31, 2025SEC
Feb 17, 20264:34 PM ETInfinitum Asset Management, LLCand 2 others13G/A9.90%4.12M shares0.00 ppfrom 9.90%Dec 31, 2025SEC
Feb 17, 20269:00 AM ETHillhouse Investment Management, Ltd.13G/A9.50%3.93M shares–Dec 31, 2025SEC
Jan 30, 20261:28 PM ETVanguard Group Inc13G/A4.52%1.87M shares−0.48 ppfrom 5.00%Below 5%Dec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G5.60%2.32M shares+0.70 ppfrom 4.90%Dec 31, 2025SEC
Nov 14, 20254:46 PM ETOctagon Capital Advisors LPand 4 others13G/A4.90%1.97M shares–Below 5%Sep 30, 2025SEC
Nov 5, 202511:26 AM ETFMR LLCand 1 other13G/A8.40%3.41M shares–Sep 30, 2025SEC
Oct 30, 20252:04 PM ETVanguard Group Inc13G5.00%2.03M sharesNewSep 30, 2025SEC
Oct 17, 20256:05 PM ETBlackRock, Inc.13G/A4.90%2.01M shares–Below 5%Sep 30, 2025SEC
Oct 15, 20254:07 PM ETHBM Healthcare Investments (Cayman) Ltd.13G5.40%2.20M sharesNewOct 8, 2025SEC
Aug 14, 20254:59 PM ETNovo Holdings A/S13G/A4.90%1.87M shares−0.30 ppfrom 5.20%Below 5%Jun 30, 2025SEC
Aug 13, 20257:43 PM ETOrbiMed Advisors LLCand 3 others13D/A7.50%3.03M shares–Aug 11, 2025SEC
Aug 13, 20257:29 PM ETSuvretta Capital Management, LLCand 2 others13G/A9.90%3.41M shares–Jun 30, 2025SEC
Aug 13, 20256:00 PM ETInfinitum Asset Management, LLCand 2 others13G9.90%3.42M shares+3.80 ppfrom 6.10%May 1, 2025SEC
May 15, 20254:36 PM ETInfinitum Asset Management, LLCand 2 others13G6.10%2.07M sharesNewMay 1, 2025SEC
Feb 14, 20259:00 PM ETNovo Holdings A/S13G5.20%1.75M sharesNewFeb 7, 2025SEC
Dec 4, 2024Suvretta Capital Management, LLC13GOld format–New–SEC
Nov 14, 2024HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)13GOld format–New–SEC
Nov 12, 2024Sofinnova Venture Partners XI, L.P.13GOld format–New–SEC
Nov 12, 2024FMR LLC13GOld format–New–SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Oct 24, 2024BlackRock, Inc.13GOld format–New–SEC
Oct 11, 2024Octagon Capital Advisors LP13GOld format–New–SEC
Feb 13, 2024LAV Fund VI, L.P.13GOld format–New–SEC
Feb 5, 2024OrbiMed Advisors LLC13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell ArriVent BioPharma, Inc. shares.

No Form 144 notices for ArriVent BioPharma, Inc. are on file.